VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
JBSJBS N.V.
$12.22$27.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksJBSBalance Sheet

JBS N.V. (JBS) Balance Sheet

12Y historyFree accessUpdated daily

The company maintains a vulnerable capital structure with a Debt/Equity ratio of 2.55 and a substantial $30.8B goodwill balance that may be susceptible to future impairment.

JBS Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14
Total Current Assets90.83B101.4B106.02B78.6B79.39B83.91B60.54B41.92B36.9B36.11B33.92B49.81B37.54B
Cash & Short-Term Investments17.8B25.98B34.76B22.12B13.18B23.24B19.68B10.03B8.94B11.74B9.36B18.84B14.91B
Cash Only16.99B25.11B34.76B22.12B13.18B23.24B19.68B10.03B8.94B11.74B9.36B18.84B8.37B
Short-Term Investments818.75M877.53M00000000006.54B
Accounts Receivable25.88B29.4B23.13B16.42B20.23B19.88B14B11.14B9.66B9.33B9.59B12.12B9.58B
Days Sales Outstanding15.9322.7820.2516.4719.2420.0118.9119.8719.420.8820.5427.1529.02
Inventory44.52B43.63B41.02B32.99B37.85B33.95B22.7B17.35B14.5B12.45B12.28B13.98B9.84B
Days Inventory Outstanding30.7238.7742.2737.1442.7842.1536.8336.6934.0832.630.0736.3735.29
Other Current Assets2.62B2.38B7.11B7.08B8.12B6.85B4.15B3.41B3.8B2.58B2.69B4.86B3.03B
Total Non-Current Assets142.1B146.94B145.92B127.53B128.72B123.34B103.26B84.42B77.25B72.59B68.9B72.69B44.5B
Property, Plant & Equipment60.33B62.58B86.05B73.37B73.16B67.05B54.74B44.06B36.28B34.53B34.09B36.48B24.73B
Fixed Asset Turnover8.80x7.53x4.85x4.96x5.25x5.41x4.94x4.64x5.01x4.73x5.00x4.47x4.87x
Goodwill30.76B32.19B33.54B29.56B30.41B32.56B28.89B24.5B23.78B22.49B21.92B24.41B12.99B
Intangible Assets9.32B10.04B11.17B9.61B10.33B12B7.82B6.05B5.82B5.51B5.01B6.89B2.45B
Long-Term Investments53.51B26.13B237.24M274.02M294.84M243.19M171.1M93.63M84.97M64.01M362.63M354.13M295.35M
Other Non-Current Assets13B13B14.92B14.71B14.52B11.48B11.65B9.71B11.29B10B7.52B4.55B4.04B
Total Assets232.92B248.34B251.94B206.13B208.11B207.25B163.8B126.34B114.15B108.7B102.82B122.5B82.04B
Asset Turnover2.53x1.90x1.65x1.76x1.85x1.75x1.65x1.62x1.59x1.50x1.66x1.33x1.47x
Asset Growth %-80.77%-1.43%22.22%-0.95%0.41%26.53%29.65%10.68%5.01%5.72%-16.07%49.31%-
Total Current Liabilities60.42B63.48B72.18B47.91B55.16B59.81B40.84B28.46B21.6B29.18B33.35B40.14B24.87B
Accounts Payable34.08B40.33B33.84B25.45B31.01B30.22B22.2B15.44B12.17B9.99B10.72B12.42B6.94B
Days Payables Outstanding24.8635.8334.8828.6635.0537.5136.0132.6528.5826.1726.2432.3124.89
Short-Term Debt6.21B6.53B17.42B8.91B11.3B14.6B6.66B4.09B3.83B13.53B18.15B20.91B13.69B
Deferred Revenue (Current)0000000000000
Other Current Liabilities12.63B6.45B9.25B4.87B4.09B5.66B4.33B3.37B1.57B2.17B1.46B3.55B2.13B
Current Ratio1.50x1.60x1.47x1.64x1.44x1.40x1.48x1.47x1.71x1.24x1.02x1.24x1.51x
Quick Ratio0.77x0.91x0.90x0.95x0.75x0.84x0.93x0.86x1.04x0.81x0.65x0.89x1.11x
Cash Conversion Cycle21.7825.7227.6424.9526.9724.6519.7323.9124.8927.3224.3731.2239.41
Total Non-Current Liabilities125.79B132.5B129.38B111.22B103.14B99.65B79.42B65.4B64.6B53.38B45.95B52.74B31.53B
Long-Term Debt105.81B111.41B106.77B92.51B84.13B80.6B61.34B50.95B53.23B43.5B38.11B44.98B26.39B
Capital Lease Obligations24.26B7.77B8.66B7.21B7.2B6.78B4.81B3.77B00000
Deferred Tax Liabilities19.64B6.43B00000000000
Other Non-Current Liabilities6.49B6.89B13.95B11.51B11.82B12.26B13.27B10.68B11.37B9.88B7.84B7.77B5.14B
Total Liabilities186.21B195.97B201.57B159.13B158.3B159.45B120.26B93.86B86.2B82.56B79.3B92.88B56.4B
Total Debt119.33B125.71B134.93B110.33B104.41B103.61B74.11B59.75B57.06B57.02B56.26B65.88B40.08B
Net Debt102.35B100.6B100.17B88.2B91.23B80.37B54.43B49.72B48.13B45.28B46.9B47.04B31.71B
Debt / Equity2.55x2.40x2.68x2.35x2.10x2.17x1.70x1.84x2.04x2.18x2.39x2.22x1.56x
Debt / EBITDA3.62x3.57x4.03x7.85x2.95x2.43x2.76x3.22x4.78x5.10x5.09x5.15x3.73x
Net Debt / EBITDA3.11x2.85x2.99x6.27x2.58x1.88x2.03x2.68x4.03x4.05x4.24x3.68x2.95x
Interest Coverage2.87x2.46x15.60x3.44x19.28x34.51x5.65x3.24x2.01x1.49x2.12x3.71x2.99x
Total Equity46.71B52.37B50.37B47B49.81B47.8B43.54B32.48B27.95B26.14B23.52B29.62B25.64B
Equity Growth %-79.86%3.97%7.17%-5.64%4.21%9.77%34.06%16.23%6.91%11.16%-20.61%15.52%-
Book Value per Share43.3449.0122.7121.1922.0919.2816.4012.1810.489.198.6010.228.90
Total Shareholders' Equity42.44B47.87B44.78B43.35B46.34B44.12B40.12B29.64B25.65B24.29B22.37B28.03B23.87B
Common Stock202.63M171.18M23.58B23.58B23.58B23.58B23.58B23.58B23.58B23.58B23.58B23.58B21.51B
Retained Earnings1.15B11.5B18.35B15.38B18.65B13.49B7.17B5.22B2.49B2.28B3.65B4.76B4.26B
Treasury Stock-3.12B-3.25B000-3.04B-303.56M-605.72M-624.14M0-1.63B-903.57M-451.7M
Accumulated OCI44.65B39.44B2.65B4.18B3.9B9.88B9.47B1.23B-10.39M-1.78B-3.44B387.79M-1.66B
Minority Interest4.27B4.51B5.59B3.65B3.46B3.68B3.42B2.85B2.3B1.85B1.14B1.59B1.77B

Key Metrics

Growth RegimeContracting
ProfitabilityStrained
Balance SheetVulnerable
Cash FlowDeteriorating
Top Statement Risk

High leverage amid cyclicality

Balance Sheet Erosion Amid Cyclicality

As reported in recent financial statements, JBS's total assets declined from $251.9B in 2024Q4 to $232.9B in 2026Q1, reflecting a contractionary trend that suggests the company's asset base is shrinking under the weight of persistent margin pressure and challenging global protein market conditions.

The reduction in total assets, coupled with a significant decline in retained earnings from $18.3B to $1.1B over the same period, indicates a rapid erosion of shareholder equity buffers. This trajectory warrants close monitoring as it suggests the company is struggling to maintain its scale while navigating a difficult phase of the livestock cycle.

Leverage Remains Elevated and Rigid

Based on the provided balance sheet data, JBS maintains a Debt/Equity ratio of 2.55 as of 2026Q1, which represents a persistent reliance on external financing that appears increasingly precarious given the company's recent inability to generate consistent operating cash flow to service these obligations.

The high leverage ratio, which has remained consistently above 2.30 for the last ten quarters, suggests that JBS is structurally dependent on debt to fund its global operations and M&A strategy. Investors should consider that this level of indebtedness limits financial flexibility and increases sensitivity to interest rate volatility.

Liquidity Buffer Shows Concerning Volatility

According to quarterly filings, JBS's cash position dropped sharply to $17.0B in 2026Q1 from a peak of $34.8B in 2024Q4, indicating that the company's liquidity buffer is being rapidly depleted to cover operational shortfalls and working capital requirements during this period of cyclical downturn.

While the current ratio of 1.50 remains technically adequate, the rapid decline in absolute cash levels suggests that the company's liquidity position is more fragile than headline ratios imply. This trend may indicate that the company is burning through its cash reserves to sustain operations, which could necessitate further financing if market conditions do not improve.

Asset Quality and Goodwill Risks

As disclosed in recent balance sheets, goodwill remains a substantial component of the asset base at $30.8B in 2026Q1, representing a significant portion of total equity that may be subject to impairment if the company's long-term earnings power continues to face downward pressure.

The reliance on goodwill, which stems from the company's aggressive acquisition history, creates a risk of non-cash write-downs that could further impair the balance sheet. The concentration of assets in PPE, which has also seen a decline, suggests that the company's ability to drive future growth through its existing physical footprint is currently constrained.

JBS — Frequently Asked Questions

Quick answers to the most common questions about buying JBS stock.

What are the total assets of JBS N.V. (JBS)?

As of 2025, JBS N.V. (JBS) had total assets of $248.34B including $101.40B in current assets.

How much debt does JBS N.V. (JBS) have?

JBS N.V. (JBS) carries total debt of $125.71B, offset by $25.98B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of JBS N.V.?

JBS N.V. (JBS) has total shareholders' equity (book value) of $47.87B ($49.01 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is JBS N.V.'s current ratio and liquidity?

JBS N.V. (JBS) reported a current ratio of 1.60x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.